Literature DB >> 10968705

Immunohistology of neuroendocrine and neuroectodermal tumors.

M R Wick1.   

Abstract

Neuroendocrine and neuroectodermal tumors are interrelated, and comprise a neoplastic family including lesions formerly termed "carcinoid," "atypical carcinoid," "small cell undifferentiated carcinoma," "primitive neuroepithelioma," "chemodectoma," and "neuroblastoma," to name but a few entities. The nosology of these neoplasms has been simplified recently, in part as a result of a better understanding of their immunophenotypes and molecular biological attributes. This review considers those immunohistochemical markers that are now generally available for diagnostic evaluation of neuroendocrine and neuroectodermal differentiation, and provides information on the relative sensitivity and specificity of each of them. Intermediate filament proteins, chromogranins, synaptophysin, CD56, CD57, CD99, neuron-specific (gamma-dimer) enolase, protein gene product 9.5, and specific neuropeptide products are discussed. The application of such determinants in regional differential diagnosis is also summarized.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968705

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  21 in total

Review 1.  Endocrine pathology in translational medicine: an overview of current and future prospects.

Authors:  Robert Yoshiyuki Osamura; Nobue Kumaki; Hiroshi Kajiwara; Noboru Egashira; Syunsuke Miyai; Susumu Takekoshi; Masanori Yasuda; Shinobu Umemura
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 2.  Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.

Authors:  José Manuel Cameselle-Teijeiro; José Antonio Mato Mato; Ovidio Fernández Calvo; Jesús García Mata
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

3.  Neuroendocrine tumours metastatic to the uvea: diagnosis by fine needle aspiration biopsy.

Authors:  Nikolaos Trichopoulos; James J Augsburger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-17       Impact factor: 3.117

4.  CD99-positive large cell neuroendocrine carcinoma with rearranged EWSR1 gene in an infant: a case of prognostically favorable tumor.

Authors:  Vicki S Malone; Sheila M Dobin; Kathleen A Jones; Ludvik R Donner
Journal:  Virchows Arch       Date:  2010-07-09       Impact factor: 4.064

5.  Uterine tumors with neuroectodermal differentiation. A report of 4 cases.

Authors:  Pavel Dundr; Daniela Fischerová; Ctibor Povýšil; Adéla Berková; Lenka Bauerová; David Cibula
Journal:  Pathol Oncol Res       Date:  2010-03-05       Impact factor: 3.201

6.  Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus).

Authors:  A D Miller; K Masek-Hammerman; K Dalecki; K G Mansfield; S V Westmoreland
Journal:  Vet Pathol       Date:  2009-07-15       Impact factor: 2.221

7.  Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas.

Authors:  Yasushi Tanaka; Toshiaki Sano; Zhi Rong Qian; Mitsuyoshi Hirokawa
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

8.  Detection of the CD56+/CD45- immunophenotype by flow cytometry in neuroendocrine malignancies.

Authors:  G J Bryson; D Lear; R Williamson; R C W Wong
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

9.  Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.

Authors:  Abdulkader Obari; Toshiaki Sano; Kenichi Ohyama; Eiji Kudo; Zhi Rong Qian; Akiko Yoneda; Nasim Rayhan; Muhammad Mustafizur Rahman; Shozo Yamada
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 10.  The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers.

Authors:  P Ferolla; A Faggiano; G Mansueto; N Avenia; M G Cantelmi; P Giovenali; M L Del Basso De Caro; F Milone; G Scarpelli; S Masone; F Santeusanio; G Lombardi; G Angeletti; A Colao
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.